🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Schizophrenia goes beyond hallucinations. @Dr_gusalva and Hara Oyedeji, PMHNP-BC, APRN, MSN, MSEd, explore its core symptom domains, treatment challenges, and the promise of xanomeline trospium chloride as a novel therapy. Watch Now: hubs.li/Q03rxtrS0

New at #HiD25: We sat down with Matthew Weir, MD, professor and director of the division of nephrology at the University of Maryland, to discuss his presentation on whether ACE/ARB inhibitors still have a place in modern treatment. Watch now: hubs.ly/Q03rzVmg0"

Phase 3 VISIONARY: sibeprenlimab cuts proteinuria by 50% in IgAN. hubs.li/Q03rz-Q40 #IgAN #Nephrology

Firefighters on a 1/3/2/3 schedule may sleep less but feel better. At #SLEEP2025, Nicole Bowles, PhD, said this staggered shift may not harm sleep overall due to better work-life balance. Check out the interview here: hcplive.com/view/staggered…

Nephrology finds itself at the beginning of a renaissance in the management of IgA nephropathy. At #ERA25, #KidneyCompass hosted @vladoperkovic for a breakdown surrounding sibeprenlimab, the historic #VISIONARY results, and more: hubs.li/Q03rz_7P0 #Nephrology

Javier Zulueta, MD, discussed Mount Sinai's incidental lung nodule program using AI tools to improve follow-up and recent findings from the program presented at #ATS2025. Watch now: hubs.li/Q03rzYqy0

Phase 3 ORIGIN: Vera Therapeutics’ Atacicept achieved a 46% reduction in proteinuria in adults with IgAN. hubs.li/Q03rzVWd0 #ERA2025

RaDaR confirms proteinuria as a viable surrogate endpoint in FSGS trials—important for accelerating drug development. hubs.li/Q03rzZsd0 #FSGS #Nephrology #ERA25

Phase 1b data show early promise for mezagitamab in IgA nephropathy, with open-label data offering insight into targeted B-cell modulation. hubs.li/Q03rz-pP0 #IgAN #ERA2025

ADU-CL-19 extension confirms long-term efficacy and tolerability of zigakibart in IgA nephropathy. Learn more: hubs.li/Q03rzZ_30

19 trial meta-analysis finds GLP-1 RAs significantly reduce adverse kidney outcomes—supporting use beyond glycemic control. hubs.li/Q03rzYX50 #Diabetes #NephroTwitter

A pair of #ERA25 studies validate belimumab’s benefit in lupus nephritis patients in real-world settings. hubs.li/Q03rzZYp0

Females with #AtopicDermatitis with up to 6 yrs of upadacitinib have comparable long-term rates of major adverse cardiovascular events, VTE, & malignancy to real-world populations with AD, new data suggest, regardless of oral contraceptive pill use. hcplive.com/view/long-term…

It’s the last day of #SLEEP2025. We spoke with Danny Eckert, PhD Flinders University on recent pharmacotherapy developments for #OSA #ObstructiveSleepApnea #SleepApnea. Check out the interview here: hcplive.com/view/latest-ph…

Check out the latest research, expert insights, and treatment updates from top anemia specialists. Learn more: hubs.li/Q03hVH5P0 #BloodDisorders #Anemia

At #SLEEP2025, Constance Fung UCLA Health shares how a masked taper + CBT-I (MTcap) helped more patients discontinue benzodiazepine receptor agonists safely. At 6 months, 73.4% in MTcap arm stopped vs 58.6% in standard taper arm. Watch here: hcplive.com/view/masked-ta…

In an interview at #SLEEP2025, Constance Fung UCLA Health shared how a masked taper + #CBT-I + nightly diary helped older adults rethink their need for sleep meds, boosting long-term #benzodiazepine discontinuation. #Sleep Watch the interview here: hcplive.com/view/masked-ta…

Have you checked out our episodes of #KidneyCompass from #ERA25? This recap offers summaries and previews for each of our 3 episodes recorded from the conference floor. Learn more: hcplive.com/view/kidney-co… #Nephrology

At #RAD2025, Dr. Amy Paller highlighted new data on disease/ family burden of #AtopicDermatitis in children aged <6 years. View her discussion here: hcplive.com/view/atopic-de…

The latest episode of Liver Lineup is here! Tune in as hosts Nancy Reau and Kimberly Brown break down another 3 notable abstracts presented at the 2025 EASL Congress in part 2 of their conference recap episode: hcplive.com/view/liver-lin…